• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:王翀,刘文,朱炯,胡增峣.新形势下国家药品质量通告态势分析与建议[J].药学研究,2023,42(3):211-213,216[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2485次   下载 2494次 本文二维码信息
码上扫一扫!
新形势下国家药品质量通告态势分析与建议
王翀1,刘文1,朱炯1,胡增峣2
字体:加大+|默认|缩小-
(1.中国食品药品检定研究院,北京 102629;2.国家药品监督管理局,北京 100037)
摘要:
国家药品质量通告是国家药监局依法依规主动公开药品质量状况的重要载体。在新媒体飞速发展和新版《药品管理法》加大假劣药品处罚力度等时代背景下,国家药品质量通告如何更好发挥作用也面临着诸多有利和不利因素。本文利用态势分析法从优势、劣势、机遇、挑战4个方面进行分析,探索国家药品质量通告在新形势下应关注的主要矛盾,并从服务监管、政策宣传、舆情监测、信用修复等多个方面为国家药品质量通告提出适应新形势的建议,以期为相关部门因势利导,扬长避短,精准施策提供参考。
关键词:  国家药品质量通告  态势分析法  信用修复  舆情监测
DOI:10.13506/j.cnki.jpr.2023.03.015
基金项目:
Analysis and suggestions of national drug quality disclosure under the new situation
WANG Chong1,LIU Wen1,ZHU Jiong1,HU Zengyao2
(1.National Institutes for Food and Drug Control,Beijing 102629, China;2.National Medical Products Administration, Beijing 100037, China)
Abstract:
National drug quality disclosure was an important way for the National Medical Products Administration to actively disclose the quality of drugs in accordance with laws and regulations. Against the backgrounds of the rapid development of new media, and the increased penalties for counterfeit and inferior drugs in the new version of the Drug Administration Law, the national drug quality disclosure was faced with many internal and external favorable and unfavorable factors. This paper analyzed strengths, weaknesses, opportunities, threats with the SWOT method, explored the main contradictions that the national drug quality disclosure should focus on under the new situation, and put forward suggestions from the aspects of strengthening drug supervision, policy publicity, public opinion monitoring, credit restoration, etc. for national drug quality disclosure to adapt to the new situation, in order to provide reference for relevant departments to make the best use of the situation, promote advantages and disadvantages, and implement precise policies.
Key words:  National drug quality Disclosure  SWOT  Credit repair  Public opinion monitoring
今日访问量:2643    总访问量:55339157
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司